About this trial
This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Between the ages of 18-65
Has already undergone a standard AKA or BKA procedure
Intractable pain
Deterioration of skin on or around stump
Disqualifiers
Inadequate health to undergo operative procedure using standard anesthesia (i.e. cardiopulmonary)
Individuals with impaired wound healing
Individuals suffering from extensive peripheral neuropathies
Active smokers
Trial design
Single group
Treatments tested in this trial
Residual limb revision
Procedure/SurgerySurgical procedure involving construction of agonist-antagonist myoneural interfaces (AMIs)
Treatment groups
Trial outcomes
Primary outcomes
Limb Morphology and Changes in Muscle Volume
Clinical examination and images from CT/MRI will be combined to construct a holistic view of the morphology of the residual limb. Imaging studies and limb measurements taken in clinic will also be used to measure muscle atrophy/hypertrophy over time.
Degree of Motor Activation of AMI Muscles and Volitional Control of Phantom Limb
Clinical examination will confirm the sliding motion of the AMI constructs with radiologic evaluation measuring the length of muscle excursion through each construct. Functional testing and testing using a prosthesis will determine how well a patient is able to volitionally control the AMI muscles.
Evidence of Proprioception
Subjective reporting combined with tests run using a prosthesis will indicate if proprioception is still intact after surgery. Results will be confirmed by monitoring brain activity during limb movement activities via fMRI.
Evidence of Sensory Perception
Subjective reporting and clinical tests of Semmes-Weinstein and two-point discrimination will determine if the patient has sensory perception on the residual limb.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Brigham and Women's Hospital
Lead sponsor
Massachusetts Institute of Technology
Collaborator